CD8A and acute myeloid leukemia: A recent study by Desai et al. [150], utilizing paired scRNA-seq and scTCR-seq on BM CD8+ T cells from healthy controls and AML patients, identified two unique effector CD8+ T cell subsets with distinct features between newly diagnosed (ND) and R/R patients with AML.